| Name | Title | Contact Details |
|---|
Adolescent AIDS Program is a Hastings, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
St. Mary`s Health Care System is a not-for-profit Catholic health care provider whose mission is to be a compassionate healing presence in the communities we serve. Founded in 1906 and sponsored by the Sisters of Mercy, St. Mary`s Health Care System is built on a foundation of values that include excellence, compassion, integrity and reverence for each person. St. Mary`s focuses on neurosciences, cardiac care, orthopedics, general medicine/general surgery, women`s and children`s health, and gastroenterology. The system includes 196-bed St. Mary`s Hospital in Athens and 25-bed St. Mary`s Good Samaritan Hospital in Greene County. Services include emergency care, intensive care, home health care/hospice services, inpatient and outpatient rehabilitation, assisted living, Alzheimer`s/dementia care, preventive care, state-of-the art diagnostic and therapeutic care and a growing network of physician practices. Named Georgia`s Hospital of the Year in 2006 and 2010, St. Mary`s is proud to be the official health care provider for the University of Georgia Athletic Association. St. Mary`s has earned the Joint Commission Gold Seal of Approval for advanced primary stroke care, advanced inpatient diabetes, heart failure care, knee replacement surgery and spine surgery.
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic
Osler Health is on the vanguard of medical providers making the transition from being service providers to clinical managers. That means we are also responsible for the totality of each patients care. Osler Health is committed to providing the right care, at the right time, and, at the right cost to deliver the best results. That is why we do not partner with hospitals so that we are rewarded for your good health, not when you lose it. Osler is ranked in the top 10% nationally for quality, and 100% of our practices use advanced technology. Osler patients are also 112% healthier relative to peer groups. Our Mission – To improve the health status of each patient efficiently, effectively and with the highest quality care. Our Vision – To transform healthcare from a Managing Sickness model to a Preserving Wellness model.
Health Media Lab is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.